多囊卵巢综合征相关遗传变异正选择的证据
该研究对1000基因组计划14个人群2504例个体进行进化分析,检测37个PCOS相关SNP的正选择信号。结果显示PCOS相关位点存在明显正选择,37个SNP中6个位于或邻近5个基因的SNP有显著正选择证据,支持PCOS遗传变异正选择假说。
要点
- PCOS相关SNP位点存在明显正选择,尤其在人类原始进化窗口内。
- 37个SNP中6个位于或邻近DENND1A、AOPEP、THADA、DGKI和UNC5C基因的SNP有显著正选择证据。
- 作者认为这些发现为PCOS的正向进化提供了额外证据,但需更大规模研究确认。
核心结论
- 本研究强化了PCOS遗传变异发生正选择的假说,并可能解释目前观察到的PCOS高患病率。
研究设计与样本
- 对1000基因组计划14个人群2504例个体进行进化分析。
- 使用6个正选择参数检测37个既往全基因组关联研究报道的PCOS相关SNP的正选择信号。
主要发现
- 综合分析进化指标,PCOS相关SNP位点存在明显正选择,尤其在人类原始进化窗口内,由显著的Tajima's D值所示。
- 与基因组背景相比,37个SNP中6个位于或邻近5个基因(DENND1A、AOPEP、THADA、DGKI和UNC5C)的SNP显示显著正选择证据。
- 其中DENND1A、AOPEP和THADA代表最确定的PCOS易感基因集。
局限性
- 第一,仅从设计良好的实验中选择了有充分文献记录的SNP。
- 第二,难以确定PCOS进化的哪种假说在起作用。
- 考虑这些基因最显著的功能后,发现它们功能广泛且彼此无明显关联。
- 作者指出分析需要更大规模研究、更多进化指标和更大数据范围来确认。
- 作者指出还需进一步研究以确定DENND1A、AOPEP、THADA、DGKI和UNC5C基因的作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Was polycystic ovary syndrome (PCOS), which impairs fertility and adheres to the evolutionary paradox, subject to evolutionary selection during ancestral times and did rapidly diminish in prevalence? SUMMARY ANSWER: This study strengthened the hypothesis that positive selection of genetic variants occurred and may account for the high prevalence of PCOS observed today. WHAT IS KNOWN ALREADY: PCOS is a complex endocrine disorder characterized by both reproductive and metabolic disturbances. As a heritable disease that impairs fertility, PCOS should diminish rapidly in prevalence; however, it is the most common cause of female subfertility globally. Few scientific genetic studies have attempted to provide evidence for the positive selection of gene variants underlying PCOS. STUDY DESIGN, SIZE, DURATION: We performed an evolutionary analysis of 2,504 individuals from 14 populations of the 1000 Genomes Project. PARTICIPANTS/MATERIALS, SETTING, METHODS: We tested the signature of positive selection for 37 single-nucleotide polymorphisms (SNPs) associated with PCOS in previous genome-wide association studies using six parameters of positive selection. MAIN RESULTS AND THE ROLE OF CHANCE: Analyzing the evolutionary indices together, there was obvious positive selection at the PCOS-related SNPs loci, especially within the original evolution window of humans, demonstrated by significant Tajima's D values. Compared to the genome background, six of the 37 SNPs in or close to five genes (DENN domain-containing protein 1A: DENND1A, chromosome 9 open reading frame 3: AOPEP, aminopeptidase O: THADA, diacylglycerol kinase iota: DGKI, and netrin receptor UNC5C: UNC5C) showed significant evidence of positive selection, among which DENND1A, AOPEP, and THADA represent the set of most established susceptibility genes for PCOS. LIMITATIONS, REASONS FOR CAUTION: First, only well-documented SNPs were selected from well-designed experiments. Second, it is difficult to determine which hypothesis of PCOS evolution is at play. After considering the most significant functions of these genes, we found that they had a wide variety of functions with no obvious association between them. WIDER IMPLICATIONS OF THE FINDINGS: Our findings provide additional evidence for the positive evolution of PCOS. Our analyses require confirmation in a larger study with more evolutionary indicators and larger data range. Further research to identify the roles of the DENND1A, AOPEP, THADA, DGKI, and UNC5C genes is also necessary. STUDY FUNDING/COMPETING INTEREST(S): This study was supported by the National Key Research and Development Program of China (2021YFC2700400 and 2021YFC2700701), Basic Science Center Program of NSFC (31988101), CAMS Innovation Fund for Medical Sciences (2021-I2M-5-001), National Natural Science Foundation of China (82192874, 31871509, and 82071606), Shandong Provincial Key Research and Development Program (2020ZLYS02), Taishan Scholars Program of Shandong Province (ts20190988), and Fundamental Research Funds of Shandong University. The authors have no conflicts of interest to disclose. TRIAL REGISTRATION NUMBER: N/A.
引用
- Yu Z, Li Y, Zhao S, et al. Evidence of positive selection of genetic variants associated with PCOS. Hum Reprod. 2023. PMID: 37982420. doi:10.1093/humrep/dead106
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。